Published Date: 02 Mar 2023
Researchers from the Barts Cancer Institute and the Francis Crick Institute at Queen Mary University of London have discovered why patients with rare blood cancers suffer from the development of poor red blood cells and...
Read Full NewsExplore anticipated FDA decisions on groundbreaking neurology drugs in 2026, shaping treatment options for various neurologic conditions.
As part of NeurologyLive®'s Year in Review, take a look at some of the top ongoing clinical trials in Alzheimer disease and dementia that may impact care.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 2, 2026.
Psychiatry in 2025: Year in Review
Gastroenterology in 2025: Year in Review
Weight-Adjusted Waist Index Predicts Cardiovascular Risk in Patients with T2D
1.
'Sugar' signatures help identify and classify pancreatic cancer cell subtypes
2.
Obesity-related cancer rising among both younger and older adults worldwide, study finds
3.
Coupling dye and fiducial marking can improve precision in pulmonary nodule surgical resection
4.
Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.
5.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
1.
Exploring the Mysteries of MGUS: Uncovering the Causes and Treatments
2.
Oncology Drug Trends 2025: FDA Approvals, Immuno-Oncology, and Clinical Trial Insights
3.
Oncological Surgery Today: Personalized, Interdisciplinary Approaches to Cancer Care
4.
Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment
5.
How Prevident is Revolutionizing Oral Care
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
4.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
5.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation